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ABSTRACT
Objective: Our previous research isolated Cucurbitacin B (CuB) and ebenone leucopentaacetate (ELP) from methanolic fruit extract of Cucumis 
callosus (MFCC). The fruits of C. callosus (Rottl.) Cogn. (Family: Cucurbitaceae) plant have been traditionally used for antioxidant, anti-inflammatory, 
and antidiabetic actions. The objective of this research was to evaluate in vitro and in vivo anticancer effect of MFCC on Ehrlich Ascites Carcinoma 
(EAC) cell lines.
Methods: In vitro anticancer assay of MFCC and standard drug, 5-fluorouracil (5-FU) was evaluated using Trypan blue and 3-(4, 5-dimethylthiazol-
yl)-2, 5-diphenyl tetrazolium bromide methods. In vivo anticancer activity of MFCC and 5-FU was also performed after 24h of EAC cells (2×106cells/
mouse) inoculation based on toxicity study for 9 consecutive days. The activity of the extract was assessed by the study of tumor volume, tumor 
weight, viable and non-viable cell count, hematological parameters, and biochemical estimations.
Results: The MFCC showed the direct antitumor effect on EAC cells in a dose-dependent manner with an IG50 value of 0.61 mg/ml. Furthermore, MFCC 
(350 mg/kg) exhibited significant (p<0.01) decrease in tumor volume, tumor weight, and viable cell count of EAC-treated mice. Hematological profile, 
biochemical estimation assay significantly (p<0.01) reverted to normal level in MFCC, and 5-FU treated mice.
Conclusion: The anticancer activity of fruits of C callosus is may be either due to the presence of CuB or/and ELP as phytoconstituent and the activity 
is comparable to standard drug 5-FU.
Keywords: Cucumis callosus, Anticancer, Ehrlich Ascites Carcinoma cell lines.
INTRODUCTION
Cancer is one of the largest causes of mortality in the world in the 
20th century and Hussain et al. 2012 explored the pattern and trends of 
cancer in Odisha. A total of 74,861 cancer inpatients were registered at 
Acharya Harihar Regional Cancer Center, Cuttack, Odisha, for the years 
2001–2011 [1,2].
Nature is always the great contributor toward this goal. Plants, vegetables, 
and herbs have been accepted as a source of cancer-preventing agent. 
Most of the pharmaceutical sectors throughout the globe carried out 
research to find a lead compound from the traditional systems of 
medicine which can block the development of cancer in a human [3,4].
Most of the cancer chemotherapeutic agents are associated with 
toxicity toward normal cells and tissues. Optimal dosing of cancer 
chemotherapeutic agents is often limited because of severe bone 
marrow depression as toxicity. It is a continuing challenge to design a 
therapy that is safer, effective, and selective [5,6]. Modern cancer biology 
focused on new anticancer drug development that may act in different 
mechanisms. In fact, those compounds having cytotoxic or cytostatic 
ability against cancer cells show a potential anticancer activity [7].
Evidence suggests that phytochemicals from fruits and vegetables 
may play an important role in reducing diabetes and cancer [8,9]. The 
proposed plant part in this study is fruits of Cucumis callosus (Rottl.) 
Cogn. (Cucurbitaceae). Fruits are oval or elliptical in shape and having 
bitter pericarp with numerous small seeds (Fig. 1) [10,11]. Tribal 
peoples of Balasore and Baripada district, Odisha, and East Midnapore 
district of West Bengal use fruits of C. callosus as a vegetable, during 
worship and for curing diabetes, epilepsy, inflammatory disorders, and 
diarrhea [12]. Ehrlich Ascites Carcinoma (EAC) cells are experimental 
tumor models used worldwide in cancer research. In 1907, Paul Ehrlich 
discovered this tumor in the mammary gland of a white mouse, and the 
tumor was named after him. It is a rapidly growing carcinoma with very 
aggressive behavior and is able to grow in almost all strains of mice. 
In ascites form, it has been used as a transplantable tumor model to 
investigate the antitumor effects of several substances [13,14].
This research evaluated the anticancer activity of C. callosus against 
Ehrlich’s ascites carcinoma bearing mice. Our previous research isolated 
Cucurbitacin B (CuB) and ebenone leucopentaacetate (ELP) from methanolic 
pericarp extract of C. callosus [15]. CuB inhibits the growth of human 
malignant cells, both in vitro and in vivo, and has been shown to be effective 
against breast cancer, head, and neck squamous cell carcinoma, pancreatic 
cancer, hepatocellular carcinoma, osteosarcoma, and myeloid leukemia 
[16,17]. Consequently, natural and semisynthetic CuBs are proposed as a 
promising source for the development of new drugs for the prevention and 
treatment of various cancers. The objective of the research was to evaluate 
in vitro and in vivo anticancer effect of fruits of C. callosus on EAC cell lines.
METHODS
Drugs and chemicals
5-fluorouracil (5-FU), 3-(4, 5-dimethylthiazol-yl)-2, 5-diphenyl 
tetrazolium bromide (MTT), and Annexin V-FITC were purchased from 
HiMedia, Mumbai, India. All other reagents used were of analytical 
grade obtained from Merck Specialties Private Limited, Mumbai, India.
Ethics statement
All the experiments were conducted according to norms and guidelines 
of CPCSEA and Institutional Animal Ethical Committee (367001/C/
CPCSEA) of University. 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i10.27439
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Plant material and extract preparation
The C. callosus fruits (15 kg) were collected and authenticated by M. 
S. Mondal, Botanical Survey of India, Kolkata, India, and the voucher 
specimen number was CNH/1-1(196)/2007/Tech-II/160. The 
methanol extract of the pericarp powder of dried fruits was prepared, 
and its yield was found to be 17.6% w/w.
Acute toxicity study
The LD50 dose of the extract was determined by administering the 
extract orally to male Swiss albino mice [18].
Assay for in vitro anticancer assay
Cell culture
EAC cells were obtained from Chittaranjan National Cancer Institute 
(CNCI, Kolkata, India) for in vitro study. The EAC cells were maintained 
in vivo in Swiss albino mice by intraperitoneal transplantation of 
2×106 cells per mouse after every 10 days at the Pharmacology Research 
Laboratory of KL Deemed to be University.
Trypan blue exclusion assay
At first, different concentrations of MFCC (0.35, 0.45, 0.55, 0.65, and 
0.75) mg/mL and 5-FU (0.02, 0.12, 0.22, 0.33, and 0.44) mg/mL were 
prepared. 1×106 EAC cells were suspended in 0.1mL of phosphate 
buffered saline (PBS, 0.2 M, and pH 7.4) and mixed with 100 mL 
of various aforementioned concentrations of the drug. The final 
concentration of drug solution was adjusted by PBS and incubated 
at 37°C for 3 h. After 3 h, equal quality of the drug-treated cells is 
mixed with Trypan blue (0.4%) and left for 1 min. It is then loaded 
in a hemocytometer, and the viable and non-viable count is recorded 
within 2 min. Viable cells do not take up color, whereas dead cells take 
up the color. However, if kept longer, live cells also generate and take 
up the color [19].
The percentage of growth inhibition is calculated using the following 
formula:
( ) 100−= ×Total cells Dead cellsGrowth inhibition %    
Total cells
MTT assay
The MTT assay was used for quantitative determination of viable cells. 
The assay was based on the conversion of the yellow tetrazolium salt-
MTT, to purple-formazan crystals by metabolically active cells. 96 well 
plates at a cell density of 2×106/ml per well in 100 μl of RPMI 1640 
were allowed to grow in a CO2 incubator for 24 h (37°C, 5% CO2). The 
medium is then removed and replaced by fresh medium containing 
different concentrations of MFCC and 5-FU for 48 h. The cells are 
incubated for 24–48 h (37°C, 5% CO2). Then, 20 μl MTT stock solutions 
(5 mg/ml in PBS) are added to each well and incubated for 5 h. The 
medium is removed and 200 μl dimethyl sulfoxide is added to each well 
to dissolve the MTT metabolic product. Then, the plate was shaken at 
150 rpm for 5 min, and the optical density was measured at 560 nm. 
Untreated cells (basal) are used as a control of viability (100%), and 
the results are expressed as percentage viability (log) relative to the 
control [20].
100= ×OD of test material% viability
OD of control
% Inhibition=100−(% viability)
Assay for in vivo anticancer assay
Transplantation of tumor
Ascitic fluid was drawn out from EAC tumor-bearing mouse. The viable 
EAC cells were counted (Trypan blue indicator) under the microscope 
and were adjusted at 2×107 cells/ml. All mice were injected with EAC 
cells suspension (0.1 ml) (ip).
Treatment schedule
30 numbers of Swiss albino mice (20–25 g) were divided into five 
groups. Group I kept as normal saline control (5 ml/kg b.w, oral) and 
Group II kept as EAC control (2×106 cells/mouse, ip). After 24 h of 
EAC transplantation animals in Groups III and IV administered MFCC 
(350) and (450) mg/kg b.w, oral respectively; Group V administered 
5-FU (30 mg/kg b.w, oral) once daily for 9 consecutive days. After 
administration of the last dose, 6 mice from each group were kept 
fasting for 18 h and blood was collected by cardiac puncture for the 
estimation of hematological and biochemical parameters. Antitumor 
activity of MFCC was assessed by observation of changes with respect 
to the parameters as per Haldar et al. 2010 [13].
Evaluation of apoptosis using fluorescence-activated cell sorting 
(FACS)
To understand the nature of cell death, we utilized double labeling 
techniques using annexin-V-FITC/PI to distinguish between apoptotic 
and necrotic cells (Fig. 2).
RESULTS
Acute toxicity study
The LD50 dose of MFCC was found to be 3500 mg/kg, b.w., p.o. in mice.
In vitro anticancer assay
The in vitro anticancer assay of the MFCC showed a direct cytotoxic 
effect in a dose-dependent manner. As the concentration of the 
drug increased, the cytotoxicity also increased. Average 50% of the 
cytotoxicity (IG50) was observed at the concentration of 0.61 mg/mL for 
MFCC and 0.346 mg/mL for 5-FU (Fig. 3).
In vivo anticancer assay
Antitumor activity of MFCC and 5-FU against EAC tumor-bearing mice 
was assessed by tumor volume, tumor weight, cell count (viable and 
non-viable), mean survival time, and percentage increase in lifespan. 
The tumor volume, tumor weight, and viable cell count were found to 
be significantly increased, and non-viable cell count was significantly 
decreased in EAC control animals when compared with normal control 
animals (Table 1). Administration of MFCC at the doses of 350 and 
450 mg/kg significantly decreased the tumor volume and viable cell 
count. Non-viable cell count was significantly higher in MFCC treated 
animals when compared with EAC control animals.
There was an increased level of white blood cell (WBC) and decreased 
the level of hemoglobin (Hb) and red blood cell (RBC) in EAC control 
group as compared to normal control group (Table 2). After treatment 
with MFCC at the doses of 350 and 450 mg/kg in EAC bearing mice 
significantly increased the RBC count, Hb content, and significantly 
reduced the WBC count as compared with the EAC control group.
Fig. 2: Schematic representation of the Annexin-V FITC assay
Fig. 1: Cucumis callosus herb, whole fruits, and their cross-
sectional parts
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FACS
Our flow cytometry data revealed that, in comparison with control 
untreated EAC cells (Fig. 4), MFCC at the doses of 350 and 450 mg/kg 
increases the apoptosis level by 12.7 and 14.8%, respectively.
Statistical analysis
The data expressed as the mean±standard error were statistically 
analyzed using one-way ANOVA followed by Dunnett’s post hoc test by 
GraphPad Prism software, version 5. p<0.05 was considered significant 
and p<0.01 as highly significant.
DISCUSSION
Our previous research evaluated hypoglycemic, antioxidant, and 
antihyperlipidemic potential of C. callosus fruit and also, proved that 
isolated CuB was the promising source for such activity [15,21]. It is 
well known that plants with antioxidant property can be effective for 
the treatment of cancer, liver damage, inflammation, etc. Hence, the 
effect of MFCC on EAC bearing mice satisfy the notion. It may be that the 
active phytoconstituent CuB reaches the target site. The plants with the 
genus Cucumis are found to be effective as anticancer agent only when 
they contain CuB. Thus presence of CuB or ELP may also be the reason 
for the MFCC to exhibit anticancer effect against EAC bearing mice.
In EAC tumor-bearing mice, a regular rapid increase in ascitic tumor 
volume was observed. Ascitic fluid is the direct nutritional source for 
tumor cells, and a rapid increase in an ascitic fluid with tumor growth 
would be a means to meet the nutritional requirement of tumor 
cells [22]. 5-FU is a key anticancer drug, with a broadspectrum of activity 
against various forms of tumors (of the brain, breast, gastrointestinal 
tract, ovary, liver, pancreas, etc.), alone or in combination with other 
chemotherapeutic agents [23,24]. Treatment with MFCC and 5-FU 
decreased the tumor volume, tumor weight, and viable tumor cell count 
of the tumor-bearing mice. Usually, in cancer chemotherapy, the major 
problems that are being encountered are a reduction in RBC and WBC 
count in blood [25]. Treatment with MFCC and 5-FU brought back the 
RBC and WBC count toward the normal levels. Hence, that was clearly 
indicated the protective action of MFCC on the hemopoietic system.
Cucurbitacins are immensely bitter taste compound and are found in 
many plants belonging to Cucurbitaceae family. CuB, D, E, I, and their 
derivatives have been studied for their anticancer activities [26]. Miliato 
et al. 2012 demonstrated in vitro and in vivo anticancer properties of 
Cucurbitacin isolated from Cayaponia racemosa [27]. The CuB exhibited 
strong cytotoxic effects against breast cancer cells in a dose-dependent 
manner and was shown to prominently alter the cytoskeletal network of 
breast cancer cells, inducing rapid morphological changes and improper 
polymerization of the microtubule network [28]. Furthermore, scientists 
discovered that CuB inhibited the tyrosine phosphorylation of STAT3, 
STAT5, and JAK2 in pancreatic cancer cell lines (Panc-1 and MiaPaCa-2) 
in vitro and in Panc-1 xenografts in vivo. Inhibition of the JAK-STAT 
pathway affected various downstream targets involved in progrowth 
signaling (e.g. c-myc, cyclins, and survivin) and apoptosis (e.g. p53, Bcl-
xL, and Bcl- 2) [29,30]. The cytotoxic effect of MFCC against EAC cells is 
probably due to downregulation of JAK and STAT proteins in EAC cells. 
The apoptotic mechanism was observed by cell cycle analysis using FACS.
In the early stages of apoptosis, the cell membrane is still intact and 
impermeable to DNA binding dye PI. However, Annexin-V binds 
specifically with phosphatidylserine is translocated to the extracellular 
leaflet of the membrane. In contrast, during necrosis, because the cell 
membrane is ruptured, these cells take up both the fluorochromes. 
The MFCC induced cell death observed in this study can occur by two 
distinct modes - apoptosis and necrosis, which can be distinguished by 
morphological and biochemical features. Annexin-V-FITC/PI staining 
of MFCC-treated EAT cells resulted in an increase in Annexin+/PI- and 
Annexin+/PI+ cells compared to the control (Annexin−/PI−), indicating 
apoptosis as a possible mode of cell death [31,32].
CONCLUSION
The present study demonstrates that the methanolic pericarp extract 
for C. callosus fruits has remarkable antitumor activity against Ehrlich’s 
ascites carcinoma cells treated mice.
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Table 1: Effect of MFCC on tumor volume, tumor weight, total cell count, viable and non-viable cell count, MST and %ILS in EAC bearing 
mice
Parameters EAC control EAC+MFCC (350 mg/kg) EAC+MFCC (450 mg/kg) EAC+5-FU (30 mg/kg)
Tumor volume (ml) 2.75±0.23 1.72±0.16# 0.88±0.14* 0.65±0.15*
Tumor weight (g) 3.16±0.14 1.18±0.06# 0.92±0.07* 0.61±0.03*
Total cell (×107 cell/ml) 9.20±0.43 5.45±0.21* 3.70±0.15* 3.91±0.08*
Viable cell (×107 cell/ml) 8.92±0.42 3.78±0.31# 1.04±0.08* 0.60±0.08*
Non-viable cell (×107 cell/ml) 0.27±0.03 1.36±0.08# 2.65±0.07* 3.18±0.06*
Viable cell (%) 94.92 75.00 28.68 14.65
Nonviable cell (%) 4.07 26.00 74.43 85.25
MST (days) 18.00 27.50 33.00 38.00
Values are mean±SE from 6 observations in each group. One-way ANOVA between EAC control group and treated groups followed by Dunnett’s test. p: #<0.05; *<0.01. 
MST: Median survival time, %ILS: Percentage increase life-span, MFCC: Methanolic fruit extract of Cucumiµs callosus, EAC: Ehrlich Ascites Carcinoma, SE: Standard error, 
ANOVA: Analysis of variance
Table 2: Effect of MFCC on hematological parameters in EAC bearing mice
Parameters Normal control EAC control EAC+MFCC (350 mg/kg) EAC+MFCC (450 mg/kg) EAC+5-FU (30 mg/kg)
RBC (cell×106/µl) 5.18±0.20 2.83±0.13a,* 4.04±0.24b,# 5.17±0.10b,* 6.08±18b,#
WBC (cell×103/µl) 4.86±0.32 7.87±0.65a,* 6.12±0.23b,# 5.08±0.23b,* 6.12±0.66b,#
Hemoglobin (g/dl) 12.46±0.38 4.60±0.28a,* 8.19±0.43b,# 10.15±0.36b,* 10.64±0.38b,#
Values are mean±SE from 6 observations in each group. One-way ANOVA between EAC control group and the treated groups followed by Dunnett’s test. aEAC control 
group versus normal group; treated groups versus EAC control group. p: #<0.05; *<0.01. MFCC: Methanolic fruit extract of Cucumis callosus, EAC: Ehrlich Ascites 
Carcinoma, SE: Standard error, RBC: Red blood cell, WBC: White blood cell, ANOVA: Analysis of variance
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